This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q79280041
rdf:type
wikibase:Item
schema:description
scientific article published on 01 July 1960 artículu científicu espublizáu en xunetu de 1960 im Juli 1960 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel наукова стаття, опублікована в липні 1960 1960 թվականի հուլիսի 1-ին հրատարակված գիտական հոդված
p:P577
wds:Q79280041-01EA15B9-7402-4AC9-8F90-149EF45D613B
wdt:P577
1960-07-01T00:00:00Z
p:P2093
wds:Q79280041-AB7AF442-2D54-45D2-A218-EF029ED8E42D wds:Q79280041-724CAE9B-2DFC-4D2F-9783-D6C9255746AA wds:Q79280041-3F9EF905-F953-42EF-B59D-88AF86C8D307 wds:Q79280041-16003347-94E1-4E56-862E-F67FEA6538D9 wds:Q79280041-34B65558-871A-40B9-9A55-7512D7F102FC
wdt:P2093
E MILLER N GLATSTEIN R D SULLIVAN C W YOUNG B CLARKSON
rdfs:label
The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine) The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine)
skos:prefLabel
The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine) The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine)
schema:name
The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine) The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine)
p:P50
wds:Q79280041-87833466-F379-4C01-8903-3E591E875F73
wdt:P50
wd:Q6283643
p:P1476
wds:Q79280041-BDA385A5-005C-45D9-B8FB-605942DEF5AC
wdt:P1476
The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine)
p:P304
wds:Q79280041-9BA60333-28F7-47B2-B6D0-5D12CD61886D
wdt:P304
77-83
p:P31
wds:Q79280041-9B07263E-BC40-48BA-90E6-E5DA2223837B
wdt:P31
wd:Q13442814
p:P921
wds:Q79280041-4CB8EAD1-9775-4879-844E-7AACEF7923C3 wds:Q79280041-547650C6-4382-4B62-AD9E-BF93090A17A1
wdt:P921
wd:Q238512 wd:Q5462356
p:P698
wds:Q79280041-A356D78D-5A4D-43B0-967B-35FD264278E3
wdtn:P698
n8:13835653
wdt:P698
13835653
p:P1433
wds:Q79280041-C505ABF9-CC6D-4F83-8364-4CC80D986E1B
wdt:P1433
wd:Q27710278
p:P478
wds:Q79280041-BF8FD7FE-9ECE-47AC-A8E8-3232B884C3FA
wdt:P478
8